Specific N-demethylation of verapamil by cytochrome P450 from

N‐demethylation biocatalysis cytochrome P450 norverapamil verapamil

Journal

Engineering in life sciences
ISSN: 1618-0240
Titre abrégé: Eng Life Sci
Pays: Germany
ID NLM: 101193313

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 17 07 2018
revised: 07 01 2019
accepted: 13 02 2019
entrez: 7 7 2020
pubmed: 25 2 2019
medline: 25 2 2019
Statut: epublish

Résumé

Norverapamil, the N-demethylated derivative of verapamil, is a novel promising leading compound for attenuating multidrug resistance with less side effects compared with verapamil. However, the efficient synthetic method for norverapamil is absent. In this study, an innovative biotechnological method based on enzymatic catalysis was presented for the high-efficient production of norverapamil. CYP105D1, a cytochrome P450 from

Identifiants

pubmed: 32625009
doi: 10.1002/elsc.201800116
pii: ELSC1198
pmc: PMC6999465
doi:

Types de publication

Journal Article

Langues

eng

Pagination

292-301

Informations de copyright

© 2019 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Déclaration de conflit d'intérêts

The authors have declared no conflict of interest.

Références

Hematol Oncol Clin North Am. 1995 Apr;9(2):363-82
pubmed: 7642468
J Biol Chem. 1990 Apr 15;265(11):6066-73
pubmed: 2180940
Bioorg Med Chem Lett. 2001 Feb 26;11(4):443-5
pubmed: 11229743
Appl Microbiol Biotechnol. 2010 Jun;87(2):595-607
pubmed: 20186410
J Biol Chem. 1964 Jul;239:2370-8
pubmed: 14209971
Curr Opin Chem Biol. 2018 Apr;43:1-7
pubmed: 29100098
Nat Chem. 2017 Jun 23;9(7):609-611
pubmed: 28644479
Cancer Res. 1989 Sep 15;49(18):5002-6
pubmed: 2569930
Biosci Rep. 2018 Mar 5;38(2):
pubmed: 29436484
Drug Metab Dispos. 2014 Apr;42(4):623-31
pubmed: 24492893
J Appl Microbiol. 2014 Dec;117(6):1549-63
pubmed: 25294646
Br J Clin Pharmacol. 1999 May;47(5):545-52
pubmed: 10336579
Curr Opin Chem Biol. 2011 Apr;15(2):241-8
pubmed: 21145278
Appl Environ Microbiol. 2004 May;70(5):2722-7
pubmed: 15128524
Can J Physiol Pharmacol. 2003 Aug;81(8):800-5
pubmed: 12897809
Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):116-21
pubmed: 8750925
Am J Hypertens. 2003 May;16(5 Pt 1):381-6
pubmed: 12745200
Appl Microbiol Biotechnol. 2019 Jan;103(2):761-776
pubmed: 30368581
J Infect Dis. 2014 Aug 1;210(3):456-66
pubmed: 24532601

Auteurs

Chen Shen (C)

Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.

Hanqing Liu (H)

Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.

Wenling Dai (W)

Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.

Xiufeng Liu (X)

Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.

Jihua Liu (J)

Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
State Key Laboratory of Natural Medicines China Pharmaceutical University Nanjing Jiangsu P. R. China.

Boyang Yu (B)

Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
State Key Laboratory of Natural Medicines China Pharmaceutical University Nanjing Jiangsu P. R. China.

Classifications MeSH